Patents by Inventor Christine Ward

Christine Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For Treating Chronic Obstructive Pulmonary Disease Using Benralizumab
    Publication number: 20200123262
    Abstract: Provided herein is are methods of treating Chronic Obstructive Pulmonary Disease (COPD) in a patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
    Type: Application
    Filed: May 24, 2019
    Publication date: April 23, 2020
    Inventors: Rene van der Merwe, Christine Ward, Ubaldo Martin, Lorin Roskos, Bing Wang
  • Methods For Treating Chronic Obstructive Pulmonary Disease Using Benralizumab
    Publication number: 20180291108
    Abstract: Provided herein is are methods of treating Chronic Obstructive Pulmonary Disease (COPD) in a patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
    Type: Application
    Filed: November 29, 2017
    Publication date: October 11, 2018
    Inventors: Rene van der Merwe, Christine Ward, Ubaldo Martin, Lorin Roskos, Bing Wang
  • METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMAB
    Publication number: 20170198049
    Abstract: Provided herein is are methods of reducing exacerbations of asthma in an asthma patient, comprising administering to the patient an effective amount of the anti-interleukin-5 receptor (IL-5R) antibody benralizumab or an antigen-binding fragment thereof.
    Type: Application
    Filed: September 2, 2016
    Publication date: July 13, 2017
    Inventors: Christine Ward, Lorin Roskos, Bing Wang, Donald Raible
  • METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BENRALIZUMAB
    Publication number: 20170107291
    Abstract: Provided herein is are methods of treating Chronic Obstructive Pulmonary Disease (COPD) in a patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
    Type: Application
    Filed: May 31, 2016
    Publication date: April 20, 2017
    Inventors: Rene van der Merwe, Christine Ward, Ubaldo Martin, Lorin Roskos, Bing Wang
  • Methods for improving asthma symptoms using benralizumab
    Patent number: 9441047
    Abstract: Provided herein are methods of improving asthma symptoms, e.g., as measured by an asthma control questionnaire, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: September 13, 2016
    Assignee: ASTRAZENECA AB
    Inventors: Christine Ward, Lorin Roskos, Bing Wang, Donald Raible
  • Methods for increasing forced expiratory volume in asthmatics using benralizumab
    Patent number: 9441046
    Abstract: Provided herein is are methods of increasing forced expiratory volume in one second (FEV1) in an asthma patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: September 13, 2016
    Assignee: ASTRAZENECA AB
    Inventors: Christine Ward, Lorin Roskos, Bing Wang, Donald Raible
  • Methods for reducing exacerbation rates of asthma using benralizumab
    Patent number: 9441037
    Abstract: Provided herein is are methods of reducing exacerbations of asthma in an asthma patient, comprising administering to the patient an effective amount of the anti-interleukin-5 receptor (IL-5R) antibody benralizumab or an antigen-binding fragment thereof.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: September 13, 2016
    Assignee: ASTRAZENECA AB
    Inventors: Christine Ward, Lorin Roskos, Bing Wang, Donald Raible
  • METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BENRALIZUMAB
    Publication number: 20150104447
    Abstract: Provided herein is are methods of treating Chronic Obstructive Pulmonary Disease (COPD) in a patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
    Type: Application
    Filed: October 14, 2014
    Publication date: April 16, 2015
    Inventors: Rene van der Merwe, Christine Ward, Ubaldo Martin, Lorin Roskos, Bing Wang
  • Methods For Increasing Forced Expiratory Volume In Asthmatics Using Benralizumab
    Publication number: 20150044203
    Abstract: Provided herein is are methods of increasing forced expiratory volume in one second (FEV1) in an asthma patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
    Type: Application
    Filed: August 7, 2014
    Publication date: February 12, 2015
    Inventors: Christine Ward, Lorin Roskos, Bing Wang, Donald Raible
  • METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMAB
    Publication number: 20150044202
    Abstract: Provided herein is are methods of reducing exacerbations of asthma in an asthma patient, comprising administering to the patient an effective amount of the anti-interleukin-5 receptor (IL-5R) antibody benralizumab or an antigen-binding fragment thereof.
    Type: Application
    Filed: August 7, 2014
    Publication date: February 12, 2015
    Inventors: Christine Ward, Lorin Roskos, Bing Wang, Donald Raible
  • METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB
    Publication number: 20150044204
    Abstract: Provided herein are methods of improving asthma symptoms, e.g., as measured by an asthma control questionnaire, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
    Type: Application
    Filed: August 7, 2014
    Publication date: February 12, 2015
    Inventors: Christine Ward, Lorin Roskos, Bing Wang, Donald Raible
  • Modeling of systemic inflammatory response to infection
    Publication number: 20070083333
    Abstract: Models for the systemic inflammatory response to infection, which involve the use of immunocompromised animals, and methods of using the models are described. These models can be used in identifying analytes or biomarker panels that can be used in staging or monitoring sepsis. The models can also be used for predicting an animal's disease outcome or in providing a prognosis for sepsis patients. Further, the invention relates to methods for evaluating potential treatments for sepsis.
    Type: Application
    Filed: November 17, 2004
    Publication date: April 12, 2007
    Inventors: Maria Vitiello, Yi Zhang, Dhammika Amaratunga, Tao Shi, Christine Ward
  • Recombinant vaccine for diseases caused by encapsulated organisms
    Patent number: 6326001
    Abstract: Vaccines for diseases caused by normally encapsulated organisms are produced by genetically modifying those organisms by deleting the genes encoding for capsule synthesis or a portion thereof sufficient to produce non-capsulated mutants of the organisms. As an example, a live, attenuated strain of Actinobacillus pleuropneumoniae genetically modified with a large deletion in a chromosomal regions of the DNA which encodes for capsule synthesis is a safe and effective vaccine against swine pleuropneumonia.
    Type: Grant
    Filed: July 15, 1998
    Date of Patent: December 4, 2001
    Assignee: Virginia Tech Intellectual Properties, Inc.
    Inventors: Thomas J. Inzana, Christine Ward
  • Recombinant vaccine for diseases caused by encapsulated organisms
    Patent number: 6086894
    Abstract: Vaccines for diseases caused by normally encapsulated organisms are produced by genetically modifying those organisms by deleting the genes encoding for capsule synthesis or a portion thereof sufficient to produce non-capsulated mutants of the organisms. As an example, a live, attenuated strain of Actinobacillus pleuropneumoniae genetically modified with a large deletion in a chromosomal regions of the DNA which encodes for capsule synthesis is a safe and effective vaccine against swine pleuropneumonia.
    Type: Grant
    Filed: June 27, 1996
    Date of Patent: July 11, 2000
    Assignee: Virginia Tech Intellectual Properties, Inc.
    Inventors: Thomas J. Inzana, Christine Ward